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undaryorpholino antisense oligonucleotides (MOs) arewidely used as a tool to achieve loss of gene function, butmany
ve off-target effects mediated by activation of Tp53 and associated apoptosis. Here, we re-examine our
eviousMO-based loss-of-function studies that had suggested thatWnt1 expressed at hindbrain boundaries in
braﬁsh promotes neurogenesis and inhibits boundary marker gene expression in the adjacent para-boundary
gions. We ﬁnd that Tp53 is highly activated and apoptosis is frequently induced by the MOs used in these
udies. Co-knockdown of Tp53 rescues the decrease in proneural and neuronalmarker expression,which is thus
off-target effect of MOs. While loss of gene expression can be attributed to cell loss through apoptotic cell
ath, surprisinglyweﬁnd that the ectopic expression of hindbrain boundarymarkers is also dependent on Tp53
tivity and its downstream apoptotic effectors. We examine whether this non-speciﬁc activation of hindbrain
undary gene expression provides insight into the endogenous mechanisms underlying boundary cell
eciﬁcation. We ﬁnd that the pro-apoptotic Bcl genes puma and bax-a are required for hindbrain boundary
arker expression, and that gain of function of the Bcl-caspase pathway leads to ectopic boundary marker
pression. These data reveal a non-apoptotic role for pro-apoptotic genes in the regulation of gene expression at
ndbrain boundaries. In light of these ﬁndings, we discuss the precautions needed in performing morpholino
ockdowns and in interpreting the data derived from
lice sites (Draper et al.,
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Critical to the application of reverse genetics in developmental
ology is the availability of tools to modify gene expression. The
chnical difﬁculty of performing a reverse genetic manipulation needs
be weighed against the robustness and reliability of achieving an
terpretable outcome. Gene knock-outs and knock-ins in the mouse,
r example, require lengthy procedures from construct assembly to
astocyst injection and chimera screening. The advantages, including
e generation of true null alleles, faithful reporter gene expression, and
ore advanced gene modiﬁcation (for example, conditional alleles and
ne replacements), justify this effort.
While the zebraﬁsh Danio rerio is well established as a model
ganism, its appeal as a system for reverse genetic studies was greatly
creased by the development of antisense interference usingmorpholino
igonucleotides (MOs, Nasevicius and Ekker, 2000). These short
tisense oligonucleotide analogs are typically designed to bind at or
ar the translational initiation site of an mRNA of interest, thereby
erically blocking translation. They have also been shown to disrupt01; Morcos, 2007), thereby blocking proper expression. Where
tibodieswere available, it has been repeatedly shown thatmorpholinos
n effectively reduce (“knockdown”) protein levels, and thereby
capitulate the phenotypes of known genetically mutant zebraﬁsh
es. One can not only eliminate gene products selectively but generate
pomorphic embryos aswell, by varying themorpholinodose. This, their
se of use andapparent reliability, provides anattractive andwidelyused
proach to reverse genetic studies in a vertebrate model.
Since the earliest publications describing the use of morpholinos in
braﬁsh, however, studies from Ekker and colleagues have found
at 15–20% of morpholinos can exhibit non-speciﬁc toxicity in the
veloping embryo (Ekker and Larson, 2001; Heasman, 2002;
asevicius and Ekker, 2000). Their recent work (Robu et al., 2007)
s further highlighted the drawbacks of using morpholinos and
entiﬁed apoptosis as a key component of their off-target effects. The
mor suppressor Tp53 is a tightly regulated transcriptional regulator
ith important roles in the maintenance of genome integrity, DNA
pair, and apoptosis of damaged and abnormal cells. Activation of
53 by radiation, chemical toxicity, or trophic factor withdrawal can
use cell cycle arrest and apoptotic cell death (Cheng et al., 1997;
gelstein et al., 2000; Vousden and Prives, 2009). Robu et al. showed
at Tp53 activation was responsible for the extensive non-speciﬁc
ll death seen inmanymorpholino-injected (morphant) embryos. By53, they were able to rescue morphant phenotypes
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these examples, loss of particular tissues was observed, and the non-
speciﬁc phenotypes were the result of apoptotic cell death.
In any manipulation where the resulting phenotype is loss of a cell
type, domain or tissue, apoptosis is often a contributing factor, and
consequently cell death is routinely assessed. Numerous mutant mouse
lines display developmental defects that are partially or completely
dependentonapoptosis, and speciﬁc aspectsof thephenotypeare rescued
by crossing into a Tp53 null background (Hettmann et al., 2000; Jones
et al., 1995; Montes de Oca Luna et al., 1995; Morgenbesser et al., 1994;
Sugo et al., 2004). By performing an analogous experiment in zebraﬁsh,
phenotypic analysis can be done in the absence of Tp53, thereby assessing
the contribution of apoptosis to the observed phenotypes (Chen et al.,
2005; Langheinrich et al., 2002; Robu et al., 2007). Because morpholinos
can cause non-speciﬁc apoptosis, however, a Tp53 knockdown cannot
distinguish between target dependent cell death and a non-speciﬁc effect
of morpholino toxicity. Verifying the speciﬁcity of a cell-death phenotype
identiﬁed by morpholino knockdown requires an alternative method,
such as a germlinemutant, deletion, or other such loss of function. The use
of morpholinos therefore has a “blind spot”, where a category of
phenotypes is not interpretable without independent conﬁrmation.
In this study, we revisit previous work from our laboratory (Amoyel
et al., 2005), taking into account recent advances in understanding of
morpholino toxicity. This previous study analysed the function ofWnt1,
which is transiently expressed at rhombomereboundaries, in relation to
neurogenesis,whichoccurs in non-boundary regions of thehindbrain. It
was found that MO-mediated knockdown of Wnt1 led to decreased
neurogenesis, and this effect was reversed by overexpression of
dominant active beta-catenin. Strikingly, Wnt1 knockdown led to
ectopic expression of hindbrain boundary markers in a temporally and
spatially restricted pattern: boundary marker expression was initially
restricted as normal, but after 18 h of development spread throughout
the hindbrain, except in rhombomere 4 (r4). Based on ﬁnding similar
phenotypes following knockdown of proneural and delta genes, a
network of interactionswas proposed inwhichWnt1 serves to promote
proneural gene expression, which in turn prevents the spreading of
boundary cell identity into non-boundary regions.
Here, we report that the decrease in proneural and neuronal marker
expression is due to off-target effects of MOs that activate the Tp53-
mediated cell death pathway. Surprisingly, we ﬁnd that many MOs also
non-speciﬁcally induce ectopic expression of boundarymarkers. In rescue
and drug-induced apoptosis experiments, we show that the reciprocal
changes to neuronal and boundary marker expression are not because
these genes regulate each other, but rather are each due to activation of
Tp53 and apoptosis effectors.We have analysedwhether the non-speciﬁc
induction of boundary marker expression in morpholino injected
embryos reﬂects an endogenous mechanism of boundary cell regulation.
We provide evidence that speciﬁc pro-apoptotic genes are required for
expression of markers of hindbrain boundaries, indicative of a non-
apoptotic role. These data provide an explanation for why morpholino
toxicity leads to ectopic gene expression: Tp53 activation throughout the
hindbrain results in widespread activation of pro-apoptotic genes, thus
driving the normal program of boundary gene expression ectopically.
These data provide the ﬁrst description of a non-apoptotic role for pro-
apoptotic genes in boundary formation. Our ﬁnding that off-target effects
ofMOs can induce speciﬁc gene expression raises issues ofwider concern,
sinceMOsarebeingusedbymany laboratories to study gene function and
regulatory networks.Wediscuss strategies to ensure that results obtained
when using MOs are not due to non-speciﬁc effects.
Materials and methods
Fish maintenance
Wild-type and transgenic zebraﬁsh embryos were obtained by
natural spawning and raised at 28.5 °C, as described (Westerﬁeld,1993). All injections were performed with control MO and/or
uninjected controls where indicated and were collected from the
same laying as experimental injections.Transgenic and mutant zebraﬁsh lines
The Krox20::GAL4line was a generous gift of Reinhard Koster
(Distel et al., 2009) and expresses GAL4 speciﬁcally in rhombomeres 3
and 5 (r3 and r5). The UAS::puma line was created by inserting the
puma CDS (Kratz et al., 2006) into a customminiTol2 (Balciunas et al.,
2006) site-ﬂanked, dual UAS vector, expressing H2B-citrine from one
5xUAS sequence (Nikolaou et al., 2009), and puma from the second
5xUAS. This construct also contains the zebraﬁsh alpha crystallin
promoter driving RFP as a genotyping aid to identify carriers. The
plasmid was injected with Tol2 transposase mRNA (Balciunas et al.,
2006), and carriers were isolated by RFP ﬂuorescence within the
retina at 4 days post-fertilization. An auto-activated zebraﬁsh
Caspase3a (Rev-Casp3a) was constructed based on the published
human version (Srinivasula et al., 1998). This coding sequence was
placed under control of a 5xUAS sequence exactly as described for
puma above. Krox20::GAL4;UAS::puma,UAS::H2B-Citrine and
Krox20::GAL4;UAS::Rev-Casp3a,UAS::H2B-Citrine double transgenic
embryos were identiﬁed by the green ﬂuorescence of GAL4 driven
H2B-Citrine in r3 and r5. The tp53 mutant line (Berghmans et al.,
2005) was acquired from the Zebraﬁsh International Resource Center
(University of Oregon, Eugene, USA).Morpholino oligonucleotides and mRNA injections
Morpholino oligonucleotides (MO)were purchased fromGene Tools
(Oregon, USA). All morpholinos were dissolved in water for 5 min at 65
°C, at 1mMandaliquotedbefore storing frozen. Beforeuse,morpholinos
were thawed for 5min at 65 °C, cooled on ice, then centrifuged. One- to
four-cell embryosweremicroinjectedwith 1.8 nl ofmorpholino diluted
inwater. All experimentswere quantiﬁed over at least two independent
replicates. The sequences of some morpholinos were described
previously and used at the indicated doses: wnt1 (0.51 pmol), ascl1a
(0.45 pmol), ascl1b (0.45 pmol), neurog1 (0.45 pmol), deltaA
(0.45 pmol, Amoyel et al., 2005) tcf3b (0.36 pmol, Dorsky et al., 2003),
rfng (0.56 pmol, TGGAGGCGACATGGGATAAGTGCAT, Cheng et al.,
2004), tp53 (0.45–0.79 pmol GCGCCATTGCTTTGCAAGAATTG, Lan-
gheinrich et al., 2002), puma splice blocker (puma SB MO, 0.56 pmol,
Sidi et al., 2008), pumaATG blocker (puma ATGMO, 0.56 pmol, Kratz et
al., 2006), bax-a (0.54 pmol, Kratz et al., 2006).
The efﬁcacy of the splice-blocking puma MO was tested in two
ways: ﬁrst, by RT-PCRwe conﬁrmed that puma transcript splicingwas
blocked by puma SB MO injection but not control MO injection
(Supplemental Fig. 3 A,B. Primer sequences are F:ATG GCC CGA CCA
GAG ATG GAA AG, R1:CTG TGA ATG TAA CCA AGC ATG ACT C, R2:TCA
TCT GAG GCC GTG CTG GTA G). Second, we conﬁrmed that Puma
depletion by MO injection abrogates gamma irradiation-induced
apoptosis in zebraﬁsh embryos (12.5 gray, Sidi et al., 2008, and
Supplemental Fig. 3C). The efﬁcacy of the bax-a MOwas also tested by
assessing gamma irradiation-induced apoptosis, against which it was
protective (12.5 gray, Supplemental Fig. 3C) as previously described
(Kratz et al., 2006). For puma MO rescue of wnt1 MO experiments, a
large set of embryos was injected ﬁrst with wnt1 MO, then half were
re-injected with puma SB MO to ensure that the two sets received the
same dose of wnt1 MO. For Bcl2-GFP injections, a plasmid containing
the coding region of zebraﬁsh Bcl2 fused to GFP was kindly provided
by the authors (Smolen et al., 2007). mRNA from this construct was
synthesized using the mMessage mMachine kit (Ambion, USA),
puriﬁed by phenol/chloroform extraction, precipitated, and injected
at 200-250 pg per embryo.
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The Bcl-2 inhibitor HA14-1 (Sigma Aldrich, H8787) was dissolved
in DMSO at 10 mM and further diluted in ﬁsh water immediately prior
to application. The dosage of 20 μM HA14-1 was established by
titration until the embryos could survive the treatment of 2.5 h
without complete degeneration.
In situ hybridization and immunohistochemistry
Embryos were grown at 28.5 °C until the desired stage, then ﬁxed in
4% paraformaldehyde/PBS overnight. Fixed embryos were then stored
in 100%methanol, or processed immediately for in situ hybridization or
immunohistochemistry. In situ hybridization probes for ascl1a, ascl1b,
neurog1, deltaA, and deltaB have previously been described (Amoyel
et al., 2005, and references therein). Commercially available ESTs were
identiﬁed by database searches for the following genes: tp53
(CK016389), p21 (CN501420), and mdm2 (EE300278)(RZPD German
Resource Centre for Genome Research GmbH, Berlin, Germany). Based
on published sequence information, PCR productswere cloned as probe
templates for the following genes: puma (Accession #DQ860151, Kratz
et al., 2006), and sema3gB (Accession #AY766121, Yu and Moens,
2005). Digoxigenin-UTP labeled riboprobeswere synthesized according
to themanufacturer's instructions (Roche) and in situ hybridization and
color development with NTB/BCIP performed as described previously
(Xu et al., 1994). Embryos were then re-ﬁxed in paraformaldehyde,
cleared in 70% gycerol/PBS, and mounted for photography on a Zeiss
Axiovision microscope ﬁtted with a Zeiss Axiocam digital camera.
Primary antibodies used are anti-EphA4 (1:450, Irving et al., 1996)
and anti-cleaved caspase-3 (1:250, #9661, Cell Signaling Technology).
Embryos were blocked in PBS+0.1% Tween20 and 5% goat serum.
Antibodies were diluted in this blocking solution and incubated
overnight at 4 °C. Detection of primary antibodies was carried out
using Alexa Fluor-488, -594 or -647 goat anti-rabbit IgG (1:450,
Invitrogen). The TUNEL cell death assay was performed as described
previously (Berghmans et al., 2005), using the In Situ Cell Death
Detection Kit, Fluorescein (Roche). Fluorescent images were captured
using a Leica TCS SP2 confocal microscope.
Results
Working on a family of novel genes, we were confounded by our
inability to rescue thephenotypes caused bymorpholino injection using
forced expression of the wild-type protein. The phenotypes that we
observed were notably similar to those described in a previous study
from our laboratory, in which MO knockdown of Wnt1 led to loss of
neurogenesis accompanied by spreading of hindbrain boundarymarker
expression (Amoyel et al., 2005). We therefore re-examined these
ﬁndings in light of emerging evidence that MOs can have off-target
effects due to Tp53-mediated activation of cell death pathways(Robu
et al., 2007).
Wnt1 morphant embryos have extensive, Tp53-dependent cell death
Zebraﬁsh embryos at the 1–4 cell stage were injected with wnt1 or
wnt1+tp53morpholinos (Amoyel et al., 2005; Langheinrich et al.,
2002). The embryos were grown until 22 h post-fertilization (hpf)
under standard conditions, ﬁxed, and processed for TUNEL to reveal
apoptotic cells. We found that uninjected embryos have very few
TUNEL-positive cells, while wnt1 morpholino-injected embryos
display extensive TUNEL labeling throughout the CNS (85%, n=27,
Fig. 1A versus B, green channel). tp53 morpholino co-injection
rescued the incidence of cell death, reducing TUNEL labeling to
control levels (100%, n=30). These data show that the wnt1
morpholino induces cell death in the CNS, and this appears to be
acting via the Tp53 pathway.Tp53 is a tightly regulated transcriptional regulator with down-
stream targets that include tp53 itself,mdm2, and the CDK inhibitor p21
(el-Deiry et al., 1993; Gartel and Tyner, 2002; Kannan et al., 2001a;
Vogelstein et al., 2000). To reveal the extent of Tp53 activation in wnt1
morphant embryos, we examined the expression pattern of these Tp53
target genes. As previously described, basal levels of these markers are
barely detectable in uninjected embryos (Fig. 1D, G, J, and Chen et al.,
2005; Robu et al., 2007). Upon injection ofwnt1MO, transcripts for tp53
(95%, n=20), mdm2 (94%, n=18), and p21 (100%, n=18) are all
strongly induced broadly throughout the anterior region of the embryo,
including the CNS (Fig. 1D–L). As expected, these Tp53 targets are
reduced to near-control levels when tp53 morpholino is co-injected.
These data conﬁrm the induction of Tp53 activity in wnt1 morphants.Wnt1 morphant phenotypes are rescued by tp53 knockdown
Expressionof proneural genesneurog1 (Blader et al., 1997), ascl1a and
1b (Allende andWeinberg, 1994), and their downstreamtargets deltaA, B,
andD(Appel andEisen, 1998;Dornseifer et al., 1997;Haddonet al., 1998),
are all reduced or lost in wnt1 morphants (Amoyel et al., 2005 and
Fig. 2A–E versus H–L). The high level of cell death in thewnt1morphants,
however, promptedus to examinewhether apoptosiswas contributing to
these phenotypes. We therefore analyzed control MO, wnt1 MO, and
wnt1+tp53 MO-injected embryos by in situ hybridization with probes
for proneural genes, anddeltaAanddeltaB.We found that the reduction in
expression of these genes in wnt1 morphants is rescued to normal levels
and pattern when Tp53 levels are knocked down (Fig. 2). This result
suggests that Wnt1 is dispensable for proneural gene expression in the
hindbrain.
We previously found that injection of wnt1 MO led to an expansion
of rhombomere boundary markers at the expense of the neurogenic
non-boundary domains. Furthermore, this boundary marker expansion
appeared to be dependent on the loss of proneural genes, which were
thought to normally repress boundary fate in a cell-autonomous
manner (Amoyel et al., 2005). Since blocking Tp53 activity in wnt1
morphants results in a restoration of proneural gene expression, we
asked whether this rescue also corrected boundary cell speciﬁcation,
and its restriction to rhombomere interfaces. We found that MO-
induced ectopic expressionof theboundarymarkers radical fringe (rfng,
Cheng et al., 2004; Qiu et al., 2004) and semaphorin-3Gb (sema3Gb,
Cooke et al., 2005; Yu and Moens, 2005) (Fig. 2M,N) is completely
eliminated when Tp53 levels are knocked down, and their expression
becomes restricted to their normal domain (Fig. 2F,G versus T, U). These
data demonstrate that Wnt1 is dispensable for the proper pattern of
boundary cell fate speciﬁcation.
The presence of tp53 MO leads to two major changes in wnt1
knockdown embryos: cell death is blocked, and proneural gene
expression is restored. Consequently, these data cannot distinguish
between the original model in which proneural genes repress
boundary fate (Amoyel et al., 2005) and one in which Tp53 and/or
cell death is causing ectopic expression of boundary markers. To
address this question directly, we performed a knockdown of all three
proneural genes, while cell death was blocked with tp53 MO. If
proneural genes repress boundary fate, boundary domains would
expand in these proneural-depleted embryos, even when Tp53
activity is blocked. Upon injection of MOs for neurog1, ascl1a, and
ascl1b and tp53 we ﬁnd that proneural genes are largely knocked
down, as revealed by the reduction in deltaA and deltaB expression
(100%, n=15 and n=18, Fig. 3A,B versus G, H). Despite this, the
boundary marker rfng remained restricted to rhombomere boundary
domains (90%, n=20, Fig. 3C versus I). These data rule out a
requirement for proneural genes in the repression of boundary
marker expression. As found previously (Amoyel et al., 2005), we
observed that triple proneural MO injection without tp53 MO induces
boundary marker expansion (100%, n=18, Fig. 3C versus F).Thus, the
Fig. 1.Wnt1 morpholino induces Tp53-dependent apoptosis. Uninjected (A, D, G, J), wnt1 MO-injected (B, E, H, K), and wnt1+tp53 MO-injected (C, F, I, L) embryos were stained to
detect dying cells (A–C, TUNEL, green channel), segment-speciﬁc marker EphA4 (A–C, red channel), and Tp53 transcriptional targets tp53 (D–F), p21 (G–I), and mdm2 (J–L). Wnt1
MO-injected embryos show increased cell death (compare A and B, green channel), which is rescued when tp53 MO is co-injected (compare B and C). Tp53 targets are induced in
wnt1 MO-injected embryos compared to uninjected controls (compare E, H, K with D, G, J), and this expression is restored to control levels when tp53MO is co-injected (compare E,
H, K and F, I, L).
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Tp53-dependent.
We have so far shown that the phenotypes of Wnt1 and proneural
gene knockdowns are dependent on Tp53 activation, rather than the
speciﬁc loss of the gene products. To determine whether this was more
broadly applicable, we asked whether the effect of morpholinos for
other components of the putative network regulating neurogenesis and
boundary restriction was also dependent on activation of Tp53. We
performed a series of morpholino injections for deltaA, tcf3b, and rfng,
which had previously been shown to induce boundary spreading
(Amoyel et al., 2005). Morpholinos were injected alone, or in
combination with tp53 MO. In all cases, boundary marker expression
was expanded when the MO was injected alone, and rescued by co-
injectionwith tp53MO(Supplemental Fig. 1D–F versusG–I). Thesedata
reinforce the conclusion that the boundary spreading phenotypes we
have observed are due to activation of Tp53, rather than a speciﬁc effect
of any particular gene knockdown.
tp53 mutants facilitate the use of toxic morpholinos
During our analysis of morpholino toxicity, we found that doses of
tp53 morpholino lower than 0.79 pmol are not always effective at
blockingMO toxicity, as revealed by persistent ectopic rfng expression
and upregulation of p21 (data not shown). One publication (Bill et al.,
2009) suggests setting the dose of tp53 MO to the same dose as the
speciﬁc MO being used. However, since effective MO doses vary
from gene to gene, andMOs have differing toxicity, varying the dose of
tp53 MOwill necessarily vary its effectiveness. To ﬁnd a more reliablemethod to avoid tp53 activity, we used a tp53 mutant line that lacks
Tp53 DNA binding activity and radiation induced apoptosis but
appears to develop normally and is homozygous viable (Berghmans
et al., 2005). To test whether the tp53 mutation in this line is also
sufﬁcient to abrogatemorpholino toxicity,we injected clutches of tp53
homozygous embryos and wild-type embryos with the same doses of
control or wnt1 MO. Whereas wnt1 morphants in the wild-type
background showed the expected expansion of rfng expression at 24
hpf (100%, n=19), wnt1 morphants in the tp53 mutant background
showed normal expression of rfng (100%, n=30), indistinguishable
from control MO-injected embryos (Supplemental Fig. 2). The tp53
mutant line therefore can be used instead of tp53 morpholino co-
injection, without the variability of knockdown, and permitting
increased doses or multiple MOs to be used together while maintaining
lower total MO levels.
Boundary domain expansion is due to events downstream of Bcl
activation
Tp53 is required for the transcriptional regulation of numerous
genes independently of its function in activating the cell death pathway
(Vogelstein et al., 2000). Therefore, the ectopic expression of hindbrain
boundary markers in wnt1 morphants could be due to direct
transcriptional regulation by Tp53, with cell death occurring as a
parallel consequence of Tp53 activation. If instead this expansion of
boundary marker expression in morphant embryos is due to activation
of cell death pathways, then inducing cell death in the absence of Tp53
activation should give a similar phenotype. To test this, we employed
Fig. 2. Tp53 knockdown rescues wnt1 MO phenotypes. In situ hybridization was performed to detect deltaA (A, H, O), deltaB (B, I, P), neurog1 (C, J, Q), ascl1a (D, K, R), ascl1b (E, L, S),
rfng (F, M, T), and sema3gb (G, N, U) in embryos injected with control (A–G), wnt1 (H–N), and wnt1+tp53 (O–U)morpholinos. Loss of expression of deltaA, deltaB, neurog1, ascl1a,
and ascl1b in the hindbrain of wnt1 morphant embryos (compare A–Ewith H–L) is rescued when Tp53 is knocked down (compare H–L with O–S). Expanded expression of boundary
markers rfng and sema3gb in wnt1 morphant embryos (compare F and G with M and N) is also rescued by Tp53 knockdown (compare M and N with T and U).
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promotes the activation of pro-apoptotic Bcl proteins resulting in
programmed cell death (Manero et al., 2006; Wang et al., 2000).
Embryos were grown until 16ss, exposed to 20 μM HA14-1 or DMSO
until 21ss, and then ﬁxed.We conﬁrmed that the drugwas inducing cell
death by antibody staining for active Caspase-3, an indicator of
apoptosis (Nicholson et al., 1995).We found that DMSO-treated control
embryos have little active Caspase-3 staining, while HA14-1-treated
embryos had extensive activated Caspase-3 staining (100%, n=12,
compare Fig. 4A andD). This resultwas conﬁrmed by TUNEL assay (data
not shown).Whereas DMSO-treated embryos show a normal pattern of
rfng expression, HA14-1 induces a dramatic expansion of rfng
expression throughout the hindbrain except in r4 (94%, n=32, Fig. 4B
versus E). These data strongly suggest that activation of the cell death
pathway is responsible for the expansion of boundary marker
expression we see in many different morphant embryos. Importantly,
HA14-1-treated embryos do not show an increase in Tp53 activity (data
not shown), nor can the injection of tp53 morpholino rescue the Rfng
expansion (Fig. 4E versus F), conﬁrming that the drug is acting
independently of Tp53 activity.
To conﬁrm that the boundary domain expansion in morpholino
injections was due to events downstream of Bcl protein activation, we
performed the reciprocal experiment and attempted to rescue the
spreading induced by the wnt1morpholino by blocking pro-apoptotic
Bcl activity. A common method for blocking Bcl-dependent apoptosis
is by forced expression of the anti-apoptotic Bcl2 protein, which is
known to bind to and thereby inhibit the function of pro-apoptotic Bcl
proteins (Adams, 2003; Chipuk and Green, 2008). We ﬁrst collected abatch of 1 cell-stage embryos, and injected half of them with mRNA
encoding a Bcl2-GFP fusion (Smolen et al., 2007). We then pooled
these embryos with their uninjected siblings and injected all of them
with the same dose of wnt1 MO. This method ensured that wnt1 MO-
injected and MO+bcl2 mRNA-injected embryos received the same
dose ofwnt1MO.While all wnt1MOalone injected embryos displayed
the characteristic spreading of Rfng expression,mostwnt1MO+bcl2-
GFP mRNA-injected embryos showed a rescue of this phenotype
(83%, n=41, Fig. 4I versus K). We also observed a rescue of the
decrease in deltaA expression in the bcl2-GFP-injected embryos (data
not shown). Therefore, blocking apoptosis in wnt1 morphants at
the level of Bcl2 rescues the phenotypes of morpholino toxicity.
These data conﬁrm that Tp53 activity is not acting directly to induce
boundary marker expression, but rather this is dependent on the cell
death pathway downstream of Bcl protein activation.
Pro-apoptotic bcl gene puma contributes to MO-induced rfng expression
Of the pro-apoptotic bcl genes, puma has been identiﬁed as a
critical component in the induction of cell death and is a direct
transcriptional target of Tp53 (Han et al., 2001; Jeffers et al., 2003;
Nakano andVousden, 2001; Sidi et al., 2008; Yu and Zhang, 2003; Yu et
al., 2001). By in situ hybridization, puma (Kratz et al., 2006)mRNAwas
not detectable in 12–24 hpf wild-type embryos (data not shown).
Injection of wnt1 MO, however, induced expression of puma
throughout the embryo, suggesting that puma is also a Tp53 target
in zebraﬁsh (data not shown). To determine whether Puma was
playing an essential role in the apoptosis caused by morpholino
Fig. 3. Proneural genes are not required to restrict boundary marker expression to
rhombomere interfaces. Embryos injected with control (A–C), neurog1+ascl1a
+ascl1b (triple, D–F) or triple+tp53 (G–I) morpholinos were hybridized with RNA
probes to deltaA (A, D, G), deltaB (B, E, H), and rfng (C, F, I). Effective proneural gene
knockdown is inferred from the decrease in downstream genes deltaA and deltaB in
triple MO-injected embryos (compare A and B with G and H). Boundary marker rfng
expression does not expand to non-boundary regions in the absence of proneural genes
when cell death is blocked (compare C and I). The expansion of rfng expression in triple
proneural gene knockdown alone (compare C and F) is therefore dependent on Tp53
activity and/or apoptosis (compare F and I).
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Puma knockdown. We injected batches of embryos with wnt1
morpholino, followed by re-injection with a splice-blocking puma
morpholino (puma SB MO, Sidi et al., 2008) in half of them. While all
wnt1 morphants had an expansion of the rfng domain at 24 hpf, most
wnt1 MO+puma SB MO-injected embryos showed a rescue of this
phenotype, especially in the posterior rhombomeres (92.5%, n=40,
Fig. 4J versus L). The partial nature of the rescue is likely explained by
an incomplete inhibition of apoptosis, as there was residual active-
caspase3 staining in the wnt1+puma SB MO co-injected embryos
(data not shown). These data indicate that Tp53 activity is acting via
Puma expression to induce ectopic boundary marker expression.
Pro-apoptotic bcl genes are required for normal boundary marker
expression
The observation that Puma is upstream of ectopic Rfng expression
under MO toxicity conditions led us to ask whether there is a normal
role for Puma in boundarymarker expression.We found that embryos
injected with puma SB+tp53 MOs showed a decrease or loss of rfng
expression at rhombomere boundaries (93%, n=87) compared withctrl+tp53 MOs (0%, n=56, Fig. 5A versus B, C). We repeated these
injections in a tp53 mutant background to avoid any MO toxicity and
additionally conﬁrmed the speciﬁcity of this result using a second,
translation blocking puma morpholino (puma ATG MO, Kratz et al.,
2006): both conditions showed a reduction or loss of rfng expression
at boundaries (100%, n=60; 80%, n=31; Fig. 5D–F and G–I). This
result indicates that the pro-apoptotic Bcl gene puma plays a role in
normal rhombomere boundary development. To determine if this
activity affected other boundary markers, we performed in situ
hybridizations for sema3Gb in Puma morphants. We found that the
higher expression of sema3Gb at rhombomere boundaries is also
reduced or lost when Puma is knocked down (data not shown).
We next asked whether forced expression of Puma could induce
ectopic Rfngexpression.Wecloned the zebraﬁshpumacoding sequence
downstream of a Gal4 upstream activator sequence cassette (5xUAS).
Stable transgenicUAS::pumaﬁshwere crossed to a krox20::GAL4driver
line, which expresses Gal4 in r3 and r5 (Distel et al., 2009). The resulting
double transgenic embryos showed obvious cell death in r3/5 at 24 hpf,
which was conﬁrmed by anti-active-caspase-3 staining (100%, n=20,
data not shown), and robust puma mRNA expression in these
rhombomeres (data not shown). In situ hybridization for rfng on a
cohort of double transgenic embryos around 24 hpf revealed smaller
r3/r5, due to cell loss, and ectopic rfng expression in non-boundary
regions speciﬁcally in these rhombomeres (ectopic rfng: 94%, n=16,
Fig. 5M versus N,O). This experiment shows that forced expression of
Puma is sufﬁcient to induce ectopic rfng expression. Taken together,
these data reveal a novel role for a pro-apoptotic bcl gene in the
regulation of hindbrain boundary cells.
The puma gain- and loss-of-function phenotypes suggested two
possible scenarios. The ﬁrst is that they reveal a novel function for this
protein, heretofore known only for its role in apoptosis. The second is
that Puma is regulating rfng expression via activation of the
mitochondrial apoptotic pathway. To distinguish between these
possibilities, we performed experiments to either block or ectopically
activate the mitochondrial pathway downstream of Puma. First, we
found that a morpholino knockdown of Bax-a (Kratz et al., 2006), the
direct downstream target of Puma in the apoptotic cascade, results in
a reduction or loss of boundary marker expression (86%, n=21, Fig. 5J
versus K, L) similar to puma morphants. Second, we activated the
apoptotic pathway by forced expression of an auto-activating
zebraﬁsh Caspase3a (see Materials and methods) in r3 and r5. In
situ hybridization for rfng on double transgenic embryos around
24 hpf revealed ectopic rfng expression in non-boundary regions
speciﬁcally in these rhombomeres (ectopic rfng: 81%, n=32, Fig. 5P
versus Q, R), similar to Puma forced-expression (Fig. 5N, O versus Q,
R). Taken together, these data support the idea that in wild-type
embryos, Puma is acting via the pro-apoptotic pathway to activate
Bax-a and Caspases in regulating hindbrain boundary-speciﬁc gene
expression.
Discussion
Our ﬁndings have uncovered previously unrecognized pitfalls to
the use of morpholinos for gene knockdown and suggest that these
reﬂect a novel non-apoptotic role for pro-apoptotic genes. We re-
examined the interpretation of a previous study (Amoyel et al., 2005),
in light of recent revelations concerning the reliability and speciﬁcity
of morpholino knockdown phenotypes. Robu et al. described a non-
target related increase in Tp53-dependent apoptosis in the CNS of
morpholino-injected zebraﬁsh (Robu et al., 2007). The mechanism by
which morpholinos activate Tp53 is not known but is sequence-
speciﬁc (Robu et al., 2007; Wickstrom et al., 2004) and may involve
cellular stress pathways. These off-target effects can mask true
phenotypes and lead to erroneous conclusions regarding genetic
relationships and developmental mechanisms. The majority of
morpholinos that we tested can induce Tp53 dependent apoptosis,
Fig. 4. Pro-apoptotic Bcl protein activity is necessary and sufﬁcient for ectopic expression of boundary markers. 16ss embryos treated for 2.5 h with 20 μM Bcl2 inhibitor HA14-1
undergo extensive apoptosis (anti-active caspase3 staining in green channel, compare A and D), and express ectopic rfng (compare B and E). Ectopic rfng expression induced by
HA14-1 treatment is still present in HA14-1-treated tp53 morphants (compare E and F), demonstrating that Tp53 is not required. To assess the requirement for Bcl activity in MO
induced ectopic rfng expression, wnt1 morphant embryos were co-injected with either Bcl2-GFP mRNA (G, I, K) or a morpholino to knockdown the pro-apoptotic Bcl gene puma (H,
J, L). Both approaches rescued the expanded rfng expression (decreased ectopic rfng in K compared to I, L compared to J). All four experiments place ectopic rfng downstream of pro-
apoptotic Bcl activity.
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et al., 2005) are rescued when cell death is blocked. Inducing
cell death by treatment with a small-molecule inhibitor of Bcls, or
forced expression of the pro-apoptotic Bcl, Puma, or Caspase3a
phenocopies wnt1 morphant phenotypes, supporting the idea that
activation of the cell death pathway is the major cause of the
phenotypes. Reciprocally, blocking the activation of apoptosis down-
stream of Tp53 using Bcl2 overexpression, or a puma knockdown
(Kratz et al., 2006; Sidi et al., 2008), rescues the wnt1 morpholino-
induced expansionof boundarydomains. Theseﬁndings are consistent
with the observation that a deletion mutant of wnt1 does not have
decreased neurogenesis in the zebraﬁsh hindbrain (Riley et al., 2004).
We now conclude that the original interpretation of the role of
Wnt1 (Amoyel et al., 2005), and by extension that of the other genes
knocked down in that study, is incorrect. The results of other studies in
which neurogenesis and/or boundaries are disrupted following MO-
mediated knockdown need to be re-examined. Moreover, it seems
unlikely that such artifacts occur only in the hindbrain.
A novel role for pro-apoptotic genes in hindbrain boundary cells
We have shown that the pro-apoptotic bcl genes puma and bax-a are
required for normal expression ofmarkers of hindbrain boundaries. Tp53,
Bcl genes, and caspases have been implicated in various non-apoptotic
developmental processes in ES cell, hematopoietic, neural and muscle
development (Lamkanﬁ et al., 2007). Inmany instances, the role involvesa requirement for pro-apoptotic gene activity in the progression of a stem
cell to a differentiation program. For example, in mouse embryonic
stem cells, caspase3 activity is required to degrade the pluripotency
factor NANOG in order for differentiation to occur (Fujita et al., 2008).
While genes in the apoptotic cascade have been implicated individually
in non-apoptotic events, there is little if any evidence for a pathway
from Tp53 to Bcl to caspases in cell differentiation. Indeed, we ﬁnd
that Tp53 is not required for normal development of hindbrain boundary
cells.
Chang et al. have suggested the balance of pro- and anti-apoptotic
bcl proteins inﬂuences the choice of neuronal versus glial fate in the
mouse cortex, independent of caspase activity (Chang et al., 2007).
This is in contrast to other ﬁndings that caspase activity affects
neuronal differentiation (Fernandoet al., 2005). In our system, Caspase
activity appears important, as the upregulation of boundary marker
rfng upon Puma overexpression also occurs following forced expres-
sion of Caspase3a. One study linkingBcl activity to a non-apoptotic role
in development (Weber and Menko, 2005) has provided a possible
answer to an important question: how can a cell activate the apoptotic
pathway and not die? Their observation that numerous endogenous
caspase inhibitors, IAPs and survivins, are expressed concomitant
with caspase activation may reveal the mechanism by which a cell
modulates the strength or character of the response to pro-apoptotic
proteins, resulting in signaling rather than death. Numerous cell death
inhibitors are present in the zebraﬁsh hindbrain (Thisse and Thisse,
2004) that can play such a role.
Fig. 5. Pro-apoptotic Bcl genes puma and bax-a are required for normal boundary marker expression. Embryos injected with either of 2 different puma morpholinos (A–I) or a bax-a
morpholino (JvL) show reduction or loss of rfngmRNA expression at the 21ss. Puma knockdown inwild-type (A–C) and tp53mutant (D–I) embryos showed equivalent reductions in
rfng expression (compare B, C and E, F, H, I). A krox20::GAL4 driver line was crossed to a UAS::puma line to force expression of Puma in rhombomeres 3 and 5. Double-positive
embryos showed increased apoptosis (data not shown) and ectopic expression of rfng within these 2 segments (compare M and N, O). Similar ectopic rfng expression was detected
when this GAL4 line was crossed to a UAS linked auto-activating Caspase3a (Rev-Casp3a, compare N, O and Q, R).
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of Puma and Caspase3 is now an important goal for understanding
how hindbrain boundaries develop. The segmentally expressed
receptor tyrosine kinase EphA4 is required for zebraﬁsh hindbrain
boundary formation (Cooke et al., 2005; Xu et al., 1995) and rfng
expression (Gerety unpublished) and might therefore activate, or be
dependent on, Puma and downstream Caspase3 activity. Several
studies support the intriguing possibility that caspases modulate Eph
receptor activity or vice versa (Depaepe et al., 2005; Furne et al.,
2009). Additionally, Notch signaling has been implicated in the
maintenance of zebraﬁsh hindbrain boundary cells (Cheng et al.,
2004; Qiu et al., 2009, and Gerety unpublished; Riley et al., 2004) and
has been linked to apoptotic genes in other contexts (Kannan et al.,
2001b; Okuyama et al., 2004). Interactions between the Eph/ephrin,
Notch, and apoptotic pathways are therefore potentially relevant
avenues for further investigations.
Off-target effects of morpholinos are not restricted to loss of cells
Loss of a cell population, reﬂected by a loss of marker expression,
is a common outcome of MO-induced non-speciﬁc cell death (Robu
et al., 2007). Our study extends this by demonstrating that the non-speciﬁc effects of morpholinos can include increased expression of
tissue-speciﬁc markers. Notably, the pattern of ectopic boundary
marker expression seemed to provide evidence for a regulatory
network, since it is temporally and spatially restricted, and correlates
with the decreased expression of proneural genes normally
expressed in a reciprocal domain. However, we ﬁnd that spreading
of boundary marker expression is not due to loss of proneural
expression but rather is dependent upon activation of the cell death
pathway, as it was rescued by Tp53 knockdown. Our ﬁndings suggest
that the reason why morpholinos can non-speciﬁcally induce ectopic
gene expression is that pro-apoptotic proteins have a normal role in
upregulating speciﬁc genes; morpholino-induced stress activates
pro-apoptotic proteins via Tp53, whereas another activating pathway
normally acts at hindbrain boundaries. There is extensive evidence
that a sufﬁcient level of activation of Tp53 and downstream genes is
required to trigger cell death (Vousden and Prives, 2009). It is
therefore possible that changes in gene expression and cell death
are not necessarily concomitant events. Consequently, in situations
in which pro-apoptotic pathways regulate cell differentiation, even
morpholinos for which elevated cell death is not detected could
nevertheless lead to changes in gene expression due to non-speciﬁc
activation of Tp53. In light of this, assaying Tp53 activity by analyzing
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itself.
Not all death is non-speciﬁc
Taken together with the ﬁndings of Robu et al. (2007), we argue that
two questions should be addressed in all experiments usingmorpholino-
mediated knockdown (Box 1), regardless of whether the phenotype
involves a loss or gain of gene expression: (1) is there increased Tp53
activity and/or cell death? This can be ascertained by detection of Tp53
target genes and the use of TUNEL staining or cleaved-caspase3
antibodies. (2) Does co-injection with tp53 morpholino rescue the
phenotypes? If it does, it is possible that the phenotype is non-speciﬁc.
However,whilemorpholinos can induce non-speciﬁc Tp53 activation and
apoptotic cell death (Robu et al., 2007), this does not imply that all cell
death phenotypes are non-speciﬁc. Numerous examples exist in which
the normal outcome of a loss of gene function is cell death (Hettmann
et al., 2000; Sugo et al., 2004). One example is the anti-apoptotic gene
mdm2, which both inhibits the function of Tp53 and targets it for
degradation (Momand et al., 1992). It is not surprising that the mouse
knock-out has speciﬁc, extensive cell death (Jones et al., 1995; Montes de
Oca Luna et al., 1995). More widely, trophic factors, mitogens, and their
receptors are often required for cell survival, and cell death is a common
outcome of abnormal cell speciﬁcation. Given what we now know about
the toxicity of morpholinos, their use to study genes displaying apoptotic
cell death as a loss-of-functionphenotype ishighlyproblematic. Anumber
of studies in zebraﬁsh claim survival roles for disease candidate genes
based onmorphant embryo apoptosis data, and it is important that these
studies be re-examined.
Injection controls
It is clear now that the “standard control” morpholino (Gene
Tools) is inadequate to establish a baseline for non-speciﬁcMO effects,
because it has inherently low levels of toxicity (Eisen and Smith, 2008;
Robu et al., 2007). Nevertheless, despite having only weak Tp53
activating toxicity, this MO should be used as a control for any
additional non-speciﬁc morpholino effects. An alternative and
commonly used control is to use mutated morpholinos, such as “5-
mismatch morpholinos”. However, advances in our understanding
of morpholino off-target effects now argue against this approach: off-
target effects are sequence-dependent, since changing 4 bases in a
morpholino can alter its toxicity (Wickstrom et al., 2004). Thus, a 5-Box 1
Recommendations for performing morpholino experiments.
1. All MOs should be tested for apoptotic phenotypes by TUNEL,
cleaved Caspase3 staining, and in situ hybridization for tp53
targets.
2. All MO experiments should be done in parallel with tp53
MO co-injected, or tp53 mutant samples to catch cell-death
related phenotypes and “non-typical” cell-death associated
phenotypes.
3. Any phenotype that is rescued by Tp53 knockdown cannot
reliably be studied bymorpholino knockdown—seekalternative
approaches.
4. Standard control morpholino, and uninjected controls, should
be used in every injection experiment.
5. A second, non-overlapping MO should be used to replicate the
phenotype.
6. Whenever feasible, supporting evidence should be provided,
either by dominant negatives, forced-expression rescue, or
gain of function phenotypes (with caveats described in text).mismatch control is unlikely to retain the same level of non-speciﬁc
toxicity of its unmutated parent MO and cannot be used as a reference
point for speciﬁcity. Reproducing a phenotype using a second, non-
overlapping morpholino (in the context of a Tp53 co-knockdown)
provides strong evidence for speciﬁcity.
Rescue to the rescue
An important strategy for establishing the speciﬁcity of knock-
down is to rescue the deﬁciency by providing exogenous gene product
back into the system. Many studies take this approach, injecting full-
length mRNAs into morphant embryos to demonstrate that the
observed phenotypes are due to the speciﬁc gene knockdown.
However, there are situations in which this approach is problematic,
for example, where ectopic or elevated expression of a gene has a
strong gain-of-function phenotype, and/or injection of mRNA will
alter development prior to the process that is being studied. More
sophisticated techniques such as heat shock or GAL4/UAS based
overexpression (Esengil and Chen, 2008; Halpern et al., 2008) can
provide a means of circumventing these difﬁculties and, when
feasible, should be used. For GAL4/UAS approaches, this will depend
upon the availability of regulatory sequences to drive the appropriate
temporal and spatial expression.
With regard to the issue of toxic morpholinos, there is at least one
potential problem with the overexpression rescue approach. Many
genes, when overexpressed, can have survival or anti-apoptotic
effects on cells. Therefore, if a morpholino loss-of-function results in
cell death that is rescued bymRNA injection, canwe conclude that this
gene is required for cell survival? Given the prevalence of non-speciﬁc
cell death, we would argue that this result is difﬁcult to interpret as it
is possible that the MO is toxic and the target has anti-apoptotic
activity. This applies not only to the question of cell survival function
but also to any rescued phenotype, as it may in fact be due to cell
death or Tp53 activity. For example, in our previous study (Amoyel
et al., 2005), forced expression of Wnt1 reversed the decrease in
neurogenesis caused by morpholino knockdown of Wnt1, but this
apparent rescue was likely due to the action of Wnt1 as a survival
factor, which presumably counteracted the effect of Tp53 activation. It
is important to emphasize that proper controls that include Tp53 co-
knockdown would alert attention to the possibility of MO toxicity.
Further controls?
The deﬁnitive control for a morpholino knockdown is a mutant
line. While this positive control may appear to obviate the need for
using a morpholino in the ﬁrst place, the ability to generate
hypomorphs, multigene knockdown embryos, and carry out ﬁrst
tier screening continue to make morpholinos an attractive tool.
Additionally, it is not realistic at present to obtain a mutant ﬁsh line
for every morpholino experiment: the efforts to generate TILLING
mutants (Wienholds et al., 2003) lag well behind the generation of
morphant phenotypes in need of validation. This limitation should be
alleviated by recent increases in TILLING throughput, advances in
targeted mutations using zinc ﬁnger nucleases, and the promise of
homologous recombination (Doyon et al., 2008; Ekker, 2008; Fan
et al., 2004; Meng et al., 2008). In the absence of these, approaches
such as the forced expression of dominant-negative versions of the
gene should be undertaken when possible to conﬁrm speciﬁcity.
How useful are morpholinos?
The appeal of morpholinos has been their ease of use and apparent
reliability. However, the prevalence of non-speciﬁc effects poses a
conundrum, particularly for the analysis of genes with unknown
function: aremorpholinos a sufﬁciently reliable tool in this pursuit? In
agreement with recent reviews of the application of morpholino
288 S.S. Gerety, D.G. Wilkinson / Developmental Biology 350 (2011) 279–289knockdown (Bill et al., 2009; Eisen and Smith, 2008), we would argue
that they are, if carried out with the appropriate controls. Although a
high proportion of morpholinos can cause non-speciﬁc apoptosis, for
many it is possible to ﬁnd a dose that gives a speciﬁc phenotype
without such toxicity. In particular, the phenotype is likely to be
speciﬁc if it still occurs following co-injection with tp53 MO, as this
should block non-speciﬁc activation of the apoptotic pathway.
However, as discussed above, the interpretation can be confounded
if cell death is a normal consequence of loss of the gene function, or if
Tp53 has a role in the process being studied. Finally, although the
current study has focused on a set of non-speciﬁc effects of
morpholinos in zebraﬁsh, it is possible that analogous difﬁculties
arise in other developmental systems and indeed do occur with other
reagents that can have off-target effects leading to activation of stress
pathways and Tp53 (siRNA, dsRNA, gripNAs: Kittler et al., 2007;
Kulkarni et al., 2006; Robu et al., 2007; Urtishak et al., 2003).
Supplementarymaterials related to this article can be found online
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